Around 826 participants will be recruited across Australia, Asia-Pacific, Europe and North America.

Natera NTRA recently announced a partnership with Aveta Biomics to support AVTA 30-01, a global Phase 3 registrational trial ...

By Sahil Pandey June 29 (Reuters) - Genetic testing firm Natera and cancer drug developer Aveta Biomics said on Monday they have partnered on a late-stage study of an experimental therapy for head and ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies ...

Applied Biomics launches Antigen Affinity Purified HCP Antibody delivering 95% HCP coverage for ELISA, WB and LC-MS workflows.

Farmington, CONN. – General Biomics, Inc. and The Jackson Laboratory (JAX) announced an expansive and exclusive intellectual property licensing agreement across six areas of human health. The ...

HAYWARD, Calif.--(BUSINESS WIRE)--Applied Biomics, Inc., a leading Proteomics service provider, adds a HCP profiling analysis using their well established high resolution, large format 2-Dimensional ...

SAN MATEO, CALIFORNIA – Maverix Biomics, Inc., a leading genomic analysis software company, today announced the appointment of J. Thomas Kent as Vice President of Research & Development. Mr. Kent has ...

The BIOMICs Group, based at the Lucio Lascaray building in the Álava/Araba campus of the University of the Basque Country (UPV/EHU), is specially known for overseeing the SGIker DNA Bank, not only ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies ...